Clinical Trial Update: Efficacy Study of Two Formulations of Erythropoietin [Phase 3]

View source ↗

Summary

A Phase 3 efficacy trial comparing two formulations of epoetin in patients undergoing hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• epoetin alfa (Formulation 1) (epoetin alfa)
• epoetin alfa (Formulation 2) (epoetin alfa)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Comparison of the Efficacy of Two Formulations of Epoetin in Patients Undergoing Hemodialysis | Phase 3 | Status: COMPLETED